science
Hosted by Manead Khin · science · EN-US
Burma | Chicago Scientist 🥼🧪🔬 Covering biotech, pharma, and healthcare companies shaping the world 🧬🏥🌎 Stream new episodes every THURSDAY! https://linktr.ee/maneadkhin #biotech #pharma #healthcare #podcast #petridishperspectives
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Public web form
Booking probability
32%
Guest openness
Selective
Sign up to generate a grounded pitch for PETRI DISH PERSPECTIVES.
Signup to Generate a PitchBurma | Chicago Scientist 🥼🧪🔬 Covering biotech, pharma, and healthcare companies shaping the world 🧬🏥🌎 Stream new episodes every THURSDAY!
PETRI DISH PERSPECTIVES is hosted by Manead Khin. The show has published 89 episodes to date.
Recent episodes include "Episode 79: Endeavor Health" (29 October 2026, 17 minutes), "Episode 78: Dr. Kristin Gleitsman on Using AI to Make Better Drug Development Decisions" (22 October 2026, 43 minutes), and "Episode 77: Revolution Medicines" (15 October 2026, 26 minutes).
PETRI DISH PERSPECTIVES publishes roughly weekly, with episodes averaging 23 minutes across 89 episodes.
Booking probability for PETRI DISH PERSPECTIVES is 32%, and the host is rated Selective on guests. PETRI DISH PERSPECTIVES requires a Pod Score of 80 or higher. PETRI DISH PERSPECTIVES's contact route on record: public web form.
The strongest fits for PETRI DISH PERSPECTIVES are Pharmaceuticals. PETRI DISH PERSPECTIVES has a science audience.
Manead Khin hosts PETRI DISH PERSPECTIVES, a science podcast with 89 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #79
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore Endeavor Health, the Chicago-area hospital system most Illinoisans have driven past but couldn’t name. Born from Evanston Hospital in 1891, grown...
Episode #78
Send us Fan Mail After years of building discovery engines inside diagnostics, Kristin Gleitsman has become one of the more skeptical voices in AI and biology. A Caltech chemistry PhD, Kristin built Veracyte’s Discovery...
Episode #77
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore Revolution Medicines, the precision oncology company that spent over a decade trying to drug one of cancer’s most notorious targets: RAS. With...
PETRI DISH PERSPECTIVES
Send us Fan Mail Welcome to your essential overview of the global biotech and pharmaceutical landscape for September 2026! This month was defined by blockbuster dealmaking, historic FDA approvals, and a growing...
PETRI DISH PERSPECTIVES
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore Jiangsu Hengrui Pharmaceuticals, the Chinese pharma giant that started as a state-owned generic drug factory in 1970 and quietly became one of the...
Episode #74
Send us Fan Mail After years of running a school on the rigid rhythm of bells, Dr. John Murphy walked away from K-12 education and into something he never trained for: performing history at bars. In this episode, John...
Episode #73
Send us Fan Mail In this episode of Petri Dish Perspectives , we explore Anew Labs , the AI drug discovery company that emerged from one of the most unexpected places in biotech: ByteDance, the parent company of TikTok...
Episode #72
Send us Fan Mail After a career spent racing against the clock in emergency rooms, Dr. Elliot Justin found himself chasing a very different kind of vital sign, one most men never think to track. Before FirmTech, he...
Episode #71
Send us Fan Mail In this episode of Petri Dish Perspectives , we take a step back from individual companies to examine one of the most powerful forces shaping the pharmaceutical industry: M&A, licensing, and the global...
PETRI DISH PERSPECTIVES
Send us Fan Mail Welcome to your essential overview of the global biotech and pharmaceutical landscape for August 2026 ! This month was defined by major dealmaking, a resurgence in biotech financing, and growing...
Episode #70
Send us Fan Mail In this episode of Petri Dish Perspectives , we explore Cellares , the biotech company trying to solve one of the biggest and least discussed challenges in cell therapy: how do you manufacture these...
Episode #69
Send us Fan Mail In this episode of Petri Dish Perspectives , we explore the remarkable rise of Summit Therapeutics , a biotech that transformed itself from an infectious-disease company into one of the most closely...
Episode #68
Send us Fan Mail In this episode of Petri Dish Perspectives , we explore the story of Guardant Health , one of the companies leading the shift toward blood-based cancer detection and precision oncology. Founded by...
Episode #67
Send us Fan Mail In this episode of Petri Dish Perspectives , we explore the story of Epic Systems, the privately held healthcare technology company that has quietly built much of the digital infrastructure behind...
PETRI DISH PERSPECTIVES
Send us Fan Mail Welcome to your essential overview of the global biotech and pharmaceutical landscape for June 2026! This month was dominated by AI cementing itself as a core part of drug discovery, with partnerships...
Episode #66
Send us Fan Mail In this episode of Petri Dish Perspectives, we explore the story of Scribe Therapeutics, one of genome editing's most ambitious companies aiming to move beyond first-generation CRISPR. Rather than...
Episode #65
Send us Fan Mail In this episode of Petri Dish Perspectives , we explore the story of Apogee Therapeutics , one of biotech's newest immunology companies aiming to redefine autoimmune disease through next-generation...
Episode #64
Send us Fan Mail In this episode of Petri Dish Perspectives , we explore the story of Conception Bio , one of the most ambitious biotechnology companies working at the intersection of stem cell biology, reproductive...
PETRI DISH PERSPECTIVES
Send us Fan Mail In this episode of Petri Dish Perspectives , we explore the story of Enveda Biosciences , one of the most exciting AI-native biotech companies redefining how drugs are discovered. While most...
Episode #62
Send us Fan Mail In this episode of Petri Dish Perspectives , we explore the story of Isomorphic Labs , Alphabet's ambitious drug discovery company born out of DeepMind's groundbreaking work on AlphaFold. From solving...
Recent guests on PETRI DISH PERSPECTIVES. Study who booked and why before you pitch.
Director of Event & Conference Management and Auxiliary Services, South Florida MotorsportsF1 Miami Grand Prix
Emergency Medicine physician, Harvard and Boston University educated, serial healthcare entrepreneur, founder of FirmTech, Healyourbody.org
CEO and Co-Founder, Scribe Therapeutics
Li Ka Shing Chancellor's Chair in Biomedical and Health Sciences at UC Berkeley, University of California, Berkeley
PitchCentric classifies PETRI DISH PERSPECTIVES under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ
